Article Information
History
- May 20, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Angharad G Davis1,2,3,*,
- Marise Bremer1,
- Georgia Schäfer1,4,
- Luke Dixon5,
- Fatima Abrahams1,
- Rene T Goliath1,
- Mpumi Maxebengula1,
- Alize Proust2,
- Anesh Chavda7,
- John Black8,
- Robert J Wilkinson1,2,3,6,
- And the HIATUS Study Consortium
- 1Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Observatory 7925, Republic of South Africa
- 2The Francis Crick Institute, Midland Road, London, NW1 1AT, United Kingdom
- 3Faculty of Life Sciences, University College London, WC1E 6BT, United Kingdom
- 4International Centre for Genetic Engineering and Biotechnology (ICGEB), Observatory, Cape Town, 7925, Republic of South Africa
- 5Imperial College NHS Healthcare Trust, Charing Cross Hospital, London, W6 8RF, United Kingdom
- 6Department of Infectious Diseases, Imperial College London, London, W12 0NN, United Kingdom
- 7Department of Radiology, West Middlesex University Hospital and Chelsea and Westminster Hospital, London, United Kingdom
- 8Department of Medicine, Walter Sisulu University, Mthatha 5117, Republic of South Africa
- ↵*Corresponding author; email: angharadgracedavis{at}gmail.com
Posted May 20, 2021.
Spectrum of neurological manifestations and systematic evaluation of cerebrospinal fluid for SARS-CoV2 in patients admitted to hospital during the COVID-19 epidemic in South Africa
